SCHEMBL7077439

SCHEMBL7077439

CCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1cccc(OCc2cccs2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ADRB2 P07550 1/20 0.44
PTGER3 P43115 1/20 0.43
KAT6A Q92794 6/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HPGD P15428 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 2/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
THRB P10828 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7078520 0.86 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ASMN1; SMN2HPGD
SCHEMBL7083365 0.86 RAB9A (0.42) ALDH1A1MEN1KMT2AADRB2SMN1; SMN2
SCHEMBL7081565 0.84 USP2 (0.47) ALDH1A1MEN1KMT2AADRB2KAT6A
SCHEMBL7083338 0.83 MEN1 (0.44) ALDH1A1MEN1KMT2AKAT6ASMN1; SMN2
SCHEMBL7080328 0.83 MEN1 (0.48) MEN1KMT2AKAT6ASMN1; SMN2HPGD
SCHEMBL7080300 0.82 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AKAT6ASMN1; SMN2
SCHEMBL7083205 0.81 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AKAT6ASMN1; SMN2
SCHEMBL7050498 0.80 SMPD1 (0.52) ALDH1A1MEN1KMT2AKAT6ASMN1; SMN2
SCHEMBL7047657 0.80 SMPD1 (0.53) ALDH1A1MEN1KMT2AKAT6ASMN1; SMN2
SCHEMBL7076746 0.80 SMPD1 (0.53) ALDH1A1MEN1KMT2AKAT6ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN ALDH1A1 385/4885MEN1 4502/4885KMT2A 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.